Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006 (EPAGGELIA)

April 29, 2009 updated by: AstraZeneca
Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

832

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Greece
      • Aleksandroupoli, Greece
        • Research Site
      • Amaliada, Greece
        • Research Site
      • Argos, Greece
        • Research Site
      • Arta, Greece
        • Research Site
      • Athina, Greece
        • Research Site
      • Chania, Greece
        • Research Site
      • Drama, Greece
        • Research Site
      • Githio, Greece
        • Research Site
      • Gounari, Greece
        • Research Site
      • Imathia, Greece
        • Research Site
      • Ioannina, Greece
        • Research Site
      • Iraklio, Greece
        • Research Site
      • Kalamata, Greece
        • Research Site
      • Katerini, Greece
        • Research Site
      • Kavala, Greece
        • Research Site
      • Komotini, Greece
        • Research Site
      • Lamia, Greece
        • Research Site
      • Larisa, Greece
        • Research Site
      • Nafpaktos, Greece
        • Research Site
      • Neapoli, Greece
        • Research Site
      • Patra, Greece
        • Research Site
      • Pirgos, Greece
        • Research Site
      • Rafina, Greece
        • Research Site
      • Serres, Greece
        • Research Site
      • Sparti, Greece
        • Research Site
      • Thessaloniki, Greece
        • Research Site
      • Trikala, Greece
        • Research Site
      • Tripoli, Greece
        • Research Site
      • Veria, Greece
        • Research Site
      • Volos, Greece
        • Research Site
      • Xalkida, Greece
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary care

Description

Inclusion Criteria:

  • Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
  • Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study

Exclusion Criteria:

  • Patients who are not willing to sign the Informed Consent Form
  • COPD Patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage (%) of Asthma treatment satisfaction and control grading
Time Frame: single visit / once
single visit / once

Secondary Outcome Measures

Outcome Measure
Time Frame
Rate of treatment compliance
Time Frame: single visit / once
single visit / once
Patients quality of life under treatment
Time Frame: single visit / once
single visit / once

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: Zachariadis Manolis, MD, Euroclinic, Athens, Greece

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Study Completion (Actual)

June 1, 2008

Study Registration Dates

First Submitted

June 9, 2008

First Submitted That Met QC Criteria

June 9, 2008

First Posted (Estimate)

June 11, 2008

Study Record Updates

Last Update Posted (Estimate)

April 30, 2009

Last Update Submitted That Met QC Criteria

April 29, 2009

Last Verified

April 1, 2009

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NIS-RGR-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on New Strategies

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe